Loading Ticker...
You Are Here: Home » Pharma

Boehringer-Eli Lilly Alliance Launches Anti-Diabetes Products In India

Elli Lilly Logo

Elli Lilly

Two known companies when it comes to diabetes drugs would team up in order to bring its first product in Indian Market. These two companies are Boehringer Ingelheim and Eli Lilly.

Among the products that will be introduced by Boehringer Ingelheim is Linagliptin which is a single dose tablet for Type 2 diabetes that is usually used by adults. This oral product will be available at chemists according to Mr Sharad Tyagi, the Chairman and Managing Director of the company.

The good thing with this drug is that it is “renal friendly”. This means that this drug is excreted from the body in ways other than the kidney. It also does not cause a low-sugar attacks and weight gain. Patients diagnosed with diabetes will surely love this drug since it does not have any side effect.

You will definitely feel safe when you use this product. It was originally launched in US, then after a year it was made available in India. The tie up of the two known companies will surely help make quality and useful drugs for everyone.

Boehringer Ingelheim Logo

Boehringer Ingelheim


Share this post

Subscribe to our updates via e-mail or get our  RSS Feed
Enter your email address:

Other Related Stories: